Hartig Drug Company has announced the addition of Nefense nasal care products at select locations in Iowa, Illinois, and Wisconsin, expanding its product lineup with drug-free options for customers seeking daily nasal hygiene solutions. The products are now available, according to a press release dated September 2, 2026.
The Nefense lineup includes hypochlorous acid nasal sprays designed for adults, children, and infants, as well as a xylitol spray. These non-medicated alternatives offer a choice for consumers who prefer not to use decongestants, catering to various age groups. Published randomized clinical research has evaluated low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms and allergic rhinitis, though the studies do not specifically test Nefense-branded products.
This expansion is significant because it brings more variety to the nasal care aisle in community pharmacies, potentially impacting consumers who are looking for non-drug approaches to maintain nasal health. With growing interest in preventive health and wellness, the availability of such products in brick-and-mortar stores may increase access for customers who prefer to shop locally. For the industry, this move reflects a trend toward integrating science-backed, drug-free options into traditional retail settings.
Hartig Drug, founded in Dubuque, Iowa, in 1904, is a family-owned pharmacy and retail company serving communities throughout Iowa, Illinois, and Wisconsin. The company provides community pharmacy services along with health, wellness, and everyday consumer products, with a focus on personalized service and strong local community relationships. By adding Nefense products, Hartig Drug continues its commitment to offering a wide range of health solutions to its customers.
Nefense, based in Dubuque, Iowa, is a nasal wellness company focused on daily nasal hygiene, airway care, and better breathing. Developed under the direction of Richard Downs, DDS, the Nefense portfolio includes HypoNasal, HypoNasal Junior, HypoBaby, and XyloClean. These products are formulated with hypochlorous acid and xylitol for routine nasal care.
The availability of Nefense products at select Hartig Drug stores could be particularly relevant for families seeking gentle options for children and infants, as the product range includes sprays specifically designed for younger age groups. Additionally, for individuals with chronic sinonasal symptoms or allergic rhinitis, the published research on hypochlorous acid nasal irrigation may offer some insight into the potential benefits of such products, although further studies are needed to establish efficacy for Nefense specifically.
Consumers interested in learning more about Nefense can visit nefense.com. For details about the full announcement, including downloadable images and bios, further information is available through the provided link. This expansion by Hartig Drug represents a step toward integrating innovative, drug-free nasal care options into community pharmacy settings, potentially influencing how consumers approach nasal health management.
